Express Scripts (ESRX) Stock Price, News & Analysis

Company Overview

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.

Key Stats

• Today's Range: $92.11 to $95.87
• 50-Day Range: $92.33 to $92.33
• 52-Week Range: $66.93 to $101.73
• Volume: 31.61 million shs
• Average Volume: 6.64 million shs
• Market Capitalization: $52.06 billion
• P/E Ratio: 13.00
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ESRX Stock Analysis - Frequently Asked Questions

How were Express Scripts' earnings last quarter?

Express Scripts Holding (NASDAQ:ESRX) posted its earnings results on Wednesday, October, 31st. The company reported $2.43 EPS for the quarter, topping the consensus estimate of $2.42 by $0.01. The firm's revenue was up 3.6% on a year-over-year basis.

What other stocks do shareholders of Express Scripts own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Express Scripts investors own include Meta Platforms (META), Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Walt Disney (DIS), Intel (INTC), Bank of America (BAC) and CVS Health (CVS).

Company Calendar

• Last Earnings: 10/31/2018
• Today: 8/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Drug Stores & Proprietary Stores
• Sub-Industry: Health Care Services
• Current Symbol: NASDAQ:ESRX
• CIK: 1532063
• Web: www.express-scripts.com
• Phone: 314-996-0900
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $7.10
• Trailing P/E Ratio: 13.00
• Forward P/E Ratio: 10.17
• P/E Growth: 1.16
• Net Income: $4.52 billion
• Net Margins: 4.83%
• Pretax Margin: N/A
• Return on Equity: 25.43%
• Return on Assets: 8.94%

Debt

• Debt-to-Equity Ratio: 0.63
• Current Ratio: 0.77
• Quick Ratio: 0.65

Sales & Book Value

• Annual Sales: $100.06 billion
• Price / Sales: 0.52
• Cash Flow: $10.49 per share
• Price / Cash Flow: 8.80
• Book Value: $32.00 per share
• Price / Book: 2.89

Miscellaneous

• Outstanding Shares: 563,860,000
• Free Float: N/A
• Market Cap: $52.06 billion
• Optionable: Optionable
• Beta: 0.88